Intuitive Surgical Shares Rise After 1Q Beat
By Christopher Kuo
Intuitive Surgical shares advanced after the company's adjusted earnings and revenue beat analysts' expectations.
Shares of the robotic surgery systems company rose 8.2% on Wednesday to $488.50. For the year, the stock is still down 14%.
The company reported first-quarter adjusted earnings of $2.50 a share after the close on Tuesday. Analysts polled by FactSet expected $2.12 a share. Revenue was $2.77 billion, ahead of the $2.62 billion analysts expected, according to FactSet.
U.S. procedures increased 15%, with notable increases in cholecystectomys and appendectomys, Chief Financial Officer Jamie Samath said during the earnings call. Outside the U.S. total procedures grew 20%, reflecting strong results in India, Canada, the United Kingdom, South Korea and Taiwan, despite challenges in China, Samath said.
The company expects to expand the role of artificial intelligence in its procedures, such as AI assisting surgeons with identifying parts of the body, Chief Executive David Rosa said.
Write to Christopher Kuo at chris.kuo@wsj.com
(END) Dow Jones Newswires
April 22, 2026 11:47 ET (15:47 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
4 Stocks to Buy Before They Rise Further
2 Undervalued Stocks to Buy Before They Rebound
The 10 Best Companies to Invest in Now
The 10 Best Dividend Stocks
United States